These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11937350

  • 1. Photo-control of nitric oxide synthase activity using a caged isoform specific inhibitor.
    Montgomery HJ, Perdicakis B, Fishlock D, Lajoie GA, Jervis E, Guy Guillemette J.
    Bioorg Med Chem; 2002 Jun; 10(6):1919-27. PubMed ID: 11937350
    [Abstract] [Full Text] [Related]

  • 2. Photocontrol of nitric oxide production in cell culture using a caged isoform selective inhibitor.
    Perdicakis B, Montgomery HJ, Abbott GL, Fishlock D, Lajoie GA, Guillemette JG, Jervis E.
    Bioorg Med Chem; 2005 Jan 03; 13(1):47-57. PubMed ID: 15582451
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K.
    Am J Respir Crit Care Med; 2000 Aug 03; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ.
    Br J Pharmacol; 1996 Aug 03; 118(7):1659-68. PubMed ID: 8842429
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer.
    Gao Y, Zhou S, Xu Y, Sheng S, Qian SY, Huo X.
    Nitric Oxide; 2019 Feb 01; 83():33-39. PubMed ID: 30590117
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y, Nikolic D, Van Breemen RB, Silverman RB.
    J Am Chem Soc; 2005 Jan 26; 127(3):858-68. PubMed ID: 15656623
    [Abstract] [Full Text] [Related]

  • 7. Structural basis for the specificity of the nitric-oxide synthase inhibitors W1400 and Nomega-propyl-L-Arg for the inducible and neuronal isoforms.
    Fedorov R, Hartmann E, Ghosh DK, Schlichting I.
    J Biol Chem; 2003 Nov 14; 278(46):45818-25. PubMed ID: 12954642
    [Abstract] [Full Text] [Related]

  • 8. 1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats.
    Jafarian-Tehrani M, Louin G, Royo NC, Besson VC, Bohme GA, Plotkine M, Marchand-Verrecchia C.
    Nitric Oxide; 2005 Mar 14; 12(2):61-9. PubMed ID: 15740979
    [Abstract] [Full Text] [Related]

  • 9. Structures of nitric oxide synthase isoforms complexed with the inhibitor AR-R17477 suggest a rational basis for specificity and inhibitor design.
    Fedorov R, Vasan R, Ghosh DK, Schlichting I.
    Proc Natl Acad Sci U S A; 2004 Apr 20; 101(16):5892-7. PubMed ID: 15071192
    [Abstract] [Full Text] [Related]

  • 10. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
    Collins JL, Shearer BG, Oplinger JA, Lee S, Garvey EP, Salter M, Duffy C, Burnette TC, Furfine ES.
    J Med Chem; 1998 Jul 16; 41(15):2858-71. PubMed ID: 9667974
    [Abstract] [Full Text] [Related]

  • 11. A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea-pig suprachiasmatic nucleus.
    Starkey SJ, Grant AL, Hagan RM.
    Br J Pharmacol; 2001 Nov 16; 134(5):1084-92. PubMed ID: 11682457
    [Abstract] [Full Text] [Related]

  • 12. Nitric oxide produced by inducible nitric oxide synthase is associated with mammary tumorigenesis in irradiated rats.
    Inano H, Onoda M.
    Nitric Oxide; 2005 Feb 16; 12(1):15-20. PubMed ID: 15631943
    [Abstract] [Full Text] [Related]

  • 13. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
    Kankuri E, Vaali K, Knowles RG, Lähde M, Korpela R, Vapaatalo H, Moilanen E.
    J Pharmacol Exp Ther; 2001 Sep 16; 298(3):1128-32. PubMed ID: 11504810
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS, Cho CH, Wang JY, Koo MW.
    Eur J Pharmacol; 2006 May 01; 536(3):301-8. PubMed ID: 16600210
    [Abstract] [Full Text] [Related]

  • 15. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase.
    Yi GB, McClendon D, Desaiah D, Goddard J, Lister A, Moffitt J, Meer RK, deShazo R, Lee KS, Rockhold RW.
    Int J Toxicol; 2003 May 01; 22(2):81-6. PubMed ID: 12745988
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
    Fishlock D, Perdicakis B, Montgomery HJ, Guillemette JG, Jervis E, Lajoie GA.
    Bioorg Med Chem; 2003 Mar 20; 11(6):869-73. PubMed ID: 12614872
    [Abstract] [Full Text] [Related]

  • 17. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors.
    Li H, Raman CS, Martásek P, Masters BS, Poulos TL.
    Biochemistry; 2001 May 08; 40(18):5399-406. PubMed ID: 11331003
    [Abstract] [Full Text] [Related]

  • 18. 3,4-Dihydro-1-isoquinolinamines: a novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency.
    Beaton H, Hamley P, Nicholls DJ, Tinker AC, Wallace AV.
    Bioorg Med Chem Lett; 2001 Apr 23; 11(8):1023-6. PubMed ID: 11327580
    [Abstract] [Full Text] [Related]

  • 19. Antisense knockdown of inducible nitric oxide synthase inhibits the relaxant effect of VIP in isolated smooth muscle cells of the mouse gastric fundus.
    Dick JM, Van Molle W, Libert C, Lefebvre RA.
    Br J Pharmacol; 2001 Sep 23; 134(2):425-33. PubMed ID: 11564662
    [Abstract] [Full Text] [Related]

  • 20. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
    Boer R, Ulrich WR, Klein T, Mirau B, Haas S, Baur I.
    Mol Pharmacol; 2000 Nov 23; 58(5):1026-34. PubMed ID: 11040050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.